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Abstract 
Background: Malaria is currently the most important human parasitic disease in the world responsible for high 
morbidity and mortality. Appropriate diagnostic methods are essential for early detection. Microscopy examination 
remains the gold standard, although molecular techniques have higher sensitivity and are very useful in cases of low 
parasitaemia and mixed infections. The objective of this study was to evaluate a new commercial molecular diagnos‑
tic technique.
Methods: A prospective, observational, multicentre study was performed between January 2015 and April 2017. All 
participants were immigrants from malaria‑endemic areas, who were divided into two groups: asymptomatic group 
and symptomatic. Samples from both groups were evaluated by a rapid diagnostic test  (ImmunoQuick® Malaria + 4 
RDT), microscopy examination, and two commercial molecular malaria tests (FTD Malaria and FTD Malaria Differentia‑
tion), then compared against an in‑house reference PCR technique.
Results: In all, 250 patients were included: 164 (65.6%) in the asymptomatic group, and 86 (34.4%) in the sympto‑
matic group. There were seven cases of asymptomatic parasitaemia (prevalence = 2.8%) that were detected only by 
molecular methods. In the symptomatic group, there were seven cases of submicroscopic malaria. The main spe‑
cies detected was Plasmodium falciparum (96.6%). The commercial molecular technique had higher sensitivity than 
the other methods (S = 96%) and a high rate of concordance with the in‑house reference PCR technique (Kappa 
score = 0.93).
Conclusions: The molecular techniques, although slower than microscopy, have adequate diagnostic accuracy and 
are very useful for the detection of P. falciparum in cases with low parasitaemia.
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Background
Malaria is an overwhelming problem in tropical develop-
ing countries. It is currently the most important human 
parasitic disease in the world and continues to be a seri-
ous public health problem [1]. More than 85% of malaria 
cases and 90% of malaria deaths occur in sub-Saharan 
Africa, mainly in young children (especially those under 
5 years old) [2].
Effective diagnostic techniques permit early and appro-
priate diagnosis of malaria since this prevents the infec-
tion from progressing to a severe stage or even death. The 
World Health Organization (WHO) recommends con-
firming all clinically suspected malaria cases before treat-
ment using a malaria-specific rapid diagnostic test (RDT) 
or by direct visualization of the parasites using standard 
microscopy [3, 4].
Light microscopy requires a high level of expertise, 
involves examining Giemsa-stained thick and thin blood 
smears on glass slides. Thick blood smears remains the 
clinical gold standard method for detecting Plasmodium 
in blood. With this technique, under optimal conditions, 
an experienced microscopist can achieve a sensitivity of 
about 50 parasites/µL of blood, although the sensitivity of 
detection in most routine diagnostic laboratories is nor-
mally much lower (in the range of approximately 50–100 
parasites per µL of blood) [1, 5]. This method, also exam-
ining thin blood smears, allows for species identification 
and quantification of parasitaemia, but it is a time-con-
suming technique for the detection of scanty parasites 
and is often difficult to use accurately for the identifica-
tion of mixed infections.
RDTs are lateral flow immunochromatographic devices 
that detect Plasmodium antigens, such as histidine-rich 
protein 2 (HRP2), produced by Plasmodium falciparum, 
parasite-specific lactate dehydrogenase (pLDH) or aldo-
lase enzyme, which is common to all species. Currently 
available RDTs have lower sensitivity than well-trained 
microscopists (≈ 100 parasites/µL) [1] and are of limited 
use [6] in cases with parasite densities below the thresh-
old of microscopy detection. The results of WHO prod-
uct testing of malaria RDTs round seven reported that 
a number of RDTs consistently detected malaria at low 
parasite densities (200  parasites/µL), had low false-pos-
itive rates and could detect P. falciparum, Plasmodium 
vivax or both of them [7].
Molecular techniques have been designed to mini-
mize the problems associated with the other methods 
described above [5]. They are highly sensitive and can 
detect ≤ 5  parasites/µL of blood (even parasitaemias as 
low as one gene copy per reaction). A significant pro-
portion of malaria infections is associated with a submi-
croscopic parasitaemia whose clinical profiles can only 
be routinely detected using polymerase chain reaction 
(PCR)-based techniques [1, 8] rather than conventional 
microscopy or RDTs. PCR is also very helpful for iden-
tifying malaria cases caused by more than one species, 
which are sometimes difficult to identify by microscopy. 
To date, the only available molecular techniques are in-
house PCR, only performed at Reference Centres.
The main objective of this study was to evaluate a new 
commercial molecular technique by comparing it with 
other diagnostic methods: thick and thin blood film 
examination, RDT and an in-house reference PCR tech-
nique, in two different population groups.
Methods
A prospective, observational, multicentre study was 
performed. Data were collected at five different hospi-
tals in Madrid, Spain (University Hospital 12 de Octu-
bre; University Hospital of Fuenlabrada, University 
Hospital Príncipe de Asturias, University Hospital Gre-
gorio Marañón, and the University Hospital Fundación 
Alcorcón) between January 2015 and April 2017.
A 5  mL blood sample was collected from all partici-
pants. All the samples were tested using all the diag-
nostic techniques: RDT  (ImmunoQuick® Malaria + 4, 
Biosynex), Giemsa-stained thin and thick blood films, the 
commercial molecular technique (C-PCR) under evalua-
tion, and the reference molecular technique (CNM-PCR).
The  ImmunoQuick® Malaria + 4 RDT is a lateral flow 
immunochromatographic method that detects the pres-
ence of P. falciparum-specific histidine-rich protein-2 
(Pf HRP-2) and pan malaria-specific pLDH (pan lactate 
dehydrogenase) in human blood. The tests were per-
formed by a microbiologist at the different hospitals, in 
accordance with the manufacturer’s instructions.
Thin and thick blood films were stained with Giemsa 
solution (1:10 dilution) for 10 min. All slides were exam-
ined under a light microscope with oil-immersion objec-
tives (100×) at the Hospital 12 de Octubre. The same 
person, a well-trained microscopist blinded to the results 
of the other tests, carried out the examination in at least 
200 visual fields. If the sample was positive, parasitaemia 
was calculated, and the result expressed in percentage 
form as the number of parasitized red blood cells.
CNM PCR was performed at the National Centre of 
Microbiology (Instituto de Salud Carlos III) by the same 
person, an expert microbiologist blinded to the results 
of the other tests. This technique allows for identifica-
tion of the four major malaria species in human blood. 
The method is a semi-nested multiplex PCR involving 
two multiplex PCR reactions for amplification of tar-
get sequences. The first reaction amplifies Plasmodium 
ssrDNA to detect Plasmodium in blood samples and 
includes an internal amplification reaction control. The 
second reaction, an identification reaction, is performed 
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to enable Plasmodium species identification [5, 9]. DNA 
extraction from 200  µL of whole blood was performed 
using the QIAamp DNA Blood Mini Kit, following the 
manufacturer’s instructions, with elution volumes of 
200  µL using the QIAcube System (QIAGEN, Hilden, 
Germany). The cost of the Nested Multiplex PCR is 
around one and a half euro per reaction plus the DNA 
isolation (5 euros).
The same blinded microbiologist who examined blood 
films also performed C-PCR at the Hospital 12 de Octu-
bre. DNA extraction from 400  µL of venous blood was 
carried out with RBC Bioscience’s  MagCore® Com-
pact Automated Nucleic Acid Extractor, and  MagCore® 
Genomic DNA Whole Blood Kit 102 extraction car-
tridges. All samples were extracted with an internal 
control to ensure the validity of the extraction and ampli-
fication processes. Purified DNA was eluted in a final 
volume of 60 µL, which was maintained stored at − 20 °C 
until amplification. This PCR method (FTD Malaria, 
Fast-Track  Diagnostics®, Esch-sur-Alzette, Luxembourg) 
consists of two different reagent kits: a generic PCR test 
for detection of Plasmodium spp, and a differential PCR 
reagent kit, able to detect four species of Plasmodium 
(P. falciparum, P. malariae, P. ovale and P. vivax). Plas-
modium knowlesi is not identified by the differential 
PCR but it would be detected by the first PCR as Plas-
modium spp. In both PCRs 10 µL of extracted DNA are 
used, as well as for negative and positive controls. The 
test consists of two processes in a single tube assay: PCR 
amplification of target DNA and Internal Control, and 
simultaneous detection of PCR amplicons by fluorescent 
dye labelled probes. Both reactions were performed using 
the CFX96™ Real-Time System,  BioRad®thermal cycler. 
All samples were analysed by generic PCR, and posi-
tive samples were further analysed by differential PCR. 
The cost of the Plasmodium spp. PCR is 22.5 euros per 
reaction (DNA isolation included), if a positive result is 
obtained 19 euros have to be added to know the species.
C-PCR is a real time PCR which only needs one ampli-
fication reaction and it can be performed at the same 
hospital, so it can be done faster and with less contamina-
tion risk than the CNM PCR. A formula can directly be 
used to quantify Ct values of differential PCR, so results 
can also be reported as gene copy numbers/mL.
Participants were divided into two groups: asympto-
matic and symptomatic group. The asymptomatic group 
included immigrants over 18  years of age originating 
from malaria-endemic areas (sub-Saharan Africa, South-
east Asia, the Indian subcontinent, Haiti and areas of the 
Amazon rainforest in South America), who presented at 
the hospital without fever or initial suspicion of malaria. 
In these cases, molecular techniques were expected to 
detect some submicroscopic carriers. Patients who fell 
into this category were located in order to offer them 
malaria treatment.
The symptomatic group included all patients who 
attended one of the participant hospitals with symptoms 
suggestive of malaria and parasites in at least one test.
The study was carried out following the ethical princi-
ples of the Helsinki Declaration. Before the samples were 
collected, participants were provided with an explana-
tion of the nature of the project and given an informed 
consent form, which they signed. Ethical review and 
clearance were obtained from the Medical and Health 
Research Ethics Committee at each of the hospitals par-
ticipating in the project.
Statistical analysis
All variables were included in an online database “RED-
Cap” (Research Electronic Data Capture) previously 
created for the study. The Kappa statistic and efficiency 
index were used to compare and rate RDT, microscopy 
and C-PCR versus the reference method, CNM-PCR. 
Diagnostic parameters such as sensitivity, specificity, pos-
itive predictive value, negative predictive value, positive 
likelihood ratio, negative likelihood ratio and efficiency 
were calculated for each diagnostic method. All estimates 
were reported with 95% confidence intervals (CI). Quan-
titative variables were expressed as means and standard 
deviation (SD) or as median (25th–75th percentiles). Cat-
egorical variables were expressed as frequencies. Rela-
tionships between categorical variables were compared 
using the χ2 test. For relationships between quantitative 
and categorical variables, the Fisher Student’s t test or the 
Mann–Whitney U test were used as appropriate. Statis-
tical significance was set at p < 0.05. Data were analysed 
using SPSS version 18.0 (SPSS Inc, Chicago, IL, EEUU) 
and EpiDat 3.1 software version (Consellería de Sani-
dade, Dirección Xeral de Saúde Pública, Xunta de Gali-
cia, Spain).
Results
During the study period, 250 patients in all were 
included: 164 (65.6%) in the asymptomatic group and 86 
(34.4%) in the symptomatic group. All 250 blood samples 
were analysed by microscopy, 184 by the RDT (132 and 
52 in the target and symptomatic groups, respectively), 
235 by CNM-PCR (153 and 82 in the target and symp-
tomatic groups, respectively), and 242 by C-PCR (160 
and 82 in target and symptomatic groups, respectively). 
Fifteen patients did not have enough blood to perform 
CNM-PCR. C-PCR could not be performed on eight 
patients for the same reason (Fig. 1).
The Immunoquick® Malaria + 4 test gave a negative 
result for most of the patients in the asymptomatic group. 
A positive result was observed in only three cases. Two of 
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these were false positives, which were confirmed by neg-
ative microscopy and negative PCR, and the other was a 
true positive. By contrast, in the symptomatic group, this 
method gave two false negative results.
In the symptomatic group, the microscopic examina-
tion was positive in 79 patients (91.8%). There were seven 
cases of symptomatic patients with a negative micros-
copy, but where molecular methods detected Plasmo-
dium. Infection was confirmed in five cases by both PCR 
methods (CNM-PCR and C-PCR) and the other two 
were detected only by C-PCR. Six cases were due to P. 
falciparum and the other one was a mixed infection due 
to P. falciparum, Plasmodium ovale and Plasmodium 
malariae. All but one had come from Equatorial Guinea.
Microscopy was negative in all patients in the asymp-
tomatic group, with the exception of one patient from 
Nigeria, who had arrived in Spain 42 days before. Seven 
cases were detected only by molecular techniques: one 
case was diagnosed by both CNM-PCR and C-PCR, three 
only by CNM-PCR, and three only by C-PCR. The preva-
lence of asymptomatic parasitaemia was 2.8%. All were P. 
falciparum infections and were detected in patients com-
ing from sub-Saharan Africa.
Overall, there were 90 cases of malaria. The main spe-
cies detected by PCR was P. falciparum (87/90: 96.6%): 8 
in the asymptomatic group, 79 in the symptomatic group. 
Other species were detected only in the symptomatic 
group. There were four cases of P. malariae and all were 
mixed infections. Plasmodium vivax was detected in 
three samples by PCR: in two cases it was the only spe-
cies detected, and the other one was a mixed infection 
with P. malariae. There were eight cases of P. ovale and 
all but one were mixed infections, as specified in Table 1. 
The two patients with P. vivax infection originated from 
India and the mixed infection with P. malariae were from 
Equatorial Guinea.
There were 10 cases of mixed infections (11.1%), all in 
the symptomatic group. Six cases were due to P. falci-
parum together with P. ovale, two to P. falciparum and 
P. malariae, and one to P. vivax and P. malariae. One 
infection was caused by three species (P. falciparum, P. 
malariae and P. ovale). Eight cases showed discrepancies 
between the results obtained by CNM-PCR and C-PCR.
The diagnostic rates obtained with each of the differ-
ent techniques in this study were then compared with 
those of the reference, CNM-PCR (Table  2). A total of 
178 blood samples were analysed by both CNM-PCR 
and RDT, 234 by both CNM-PCR and microscopy (thick 
blood slide), and 228 by both CNM-PCR and C-PCR.
Blood samples (n=250) 


















Fig. 1 Distribution of blood samples collected according to each group of patients
Table 1 Species detected in the asymptomatic and 
symptomatic groups of patients
a All were mixed infections: two were P. malariae + P. falciparum, one P. 
malariae + P. vivax and one P. malariae + P. falciparum + P. ovale
b One of these was a mixed infection with P. malariae
c Seven cases were mixed infections: six with P. falciparum, one with P. 
falciparum + P. malariae + P. ovale
Detected species  





Plasmodium falciparum (n = 87) 8 79
Plasmodium malariae (n = 4) 0 4a
Plasmodium vivax (n = 3) 0 3b
Plasmodium ovale (n = 8) 0 8c
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Overall, when compared with microscopy, the molec-
ular techniques resulted in an increase in the detection 
of infection, with high concordance (Kappa score 0.91) 
between microscopic examination of thick blood slides 
and PCR. There was a high concordance between the 
two molecular methods, showing a Kappa score of 0.93. 
C-PCR was able to detect more cases of malaria infec-
tion, as well as mixed infections.
Discussion
It is very important to make a definitive diagnosis and 
confirm malaria disease. Although microscopy remains 
the gold standard for malaria diagnosis and is faster than 
molecular techniques, it has major limitations such as 
low sensitivity, difficulties associated with quality control 
and standardization and the need for ongoing training 
and evaluation [10–13]. For this reason, PCR assays are 
increasingly being used in the diagnosis of malaria [3, 10, 
14, 15]. Based on published findings, studies have dem-
onstrated that PCR methods are more sensitive and allow 
for more accurate species identification than micros-
copy [10, 15, 16]. On the other hand they require well-
trained staff and time to obtain a result is longer than for 
microscopy (around 3 h compared to no more than 1 h 
for microscopy).
As a result of globalization, the number of imported 
malaria cases has increased, mainly due to immigrants 
from malaria-endemic areas who have developed a semi-
immune status [17–19], which they gradually lose when 
they live outside their home country. As a result, indi-
viduals in this population are at a high risk of contracting 
malaria when they travel, they tend to have low-density 
parasitaemia, and may be misdiagnosed if only micros-
copy and RDTs are employed [4]. The presence of these 
asymptomatic carriers could be a risk in countries where 
malaria is not endemic, but where there are vectors, as in 
Spain, which is a malaria-free country with anophelism 
(Anopheles atroparvus).
For all these reasons, a new commercial technique was 
evaluated and its usefulness in routine malaria diagno-
sis by comparing it with a RDT, microscopy, and a ref-
erence PCR technique. These data show that microscopy 
gives a more accurate diagnosis than the dipstick RDT 
 ImmunoQuick® Malaria + 4 RDT, but has lower diag-
nostic capacity (sensitivity 88.5%) than PCR. More spe-
cifically, 14 out of 90 patients had a negative microscopy 
and were diagnosed only by PCR. The thick blood slide 
examination was positive in only one patient with very 
low parasitaemia (< 0.01%) in the asymptomatic group. 
In malaria infections where parasitaemia is very low, 
diagnosis can easily be missed if it is not possible to use 
a molecular technique and expert microscopists are not 
available.
The sensitivity and specificity of RDT  ImmunoQuick® 
Malaria + 4 RDT were both less than 90%, with a Kappa 
score of 0.65 against CNM-PCR. Its usefulness in malaria 
diagnosis lies mainly in the fact that it is quick and easy 
to perform and does not require trained staff. A product 
evaluation by the manufacturer, reporting findings from 
230 samples, showed that the sensitivity and specificity of 
 Immunoquick® Malaria + 4 versus microscopic examina-
tion of thick and thin blood smears were 70.5% and 100% 
for pLDH, and 98.8% and 100% for Pf HRP-2, respec-
tively. In the present study, sensitivity and specificity were 
88.8% and 84.2%, respectively, lower than those specified 
by the manufacturer. In the asymptomatic group, the 
RDT yielded two false positive results, confirmed by neg-
ative microscopy and negative PCR. This test also gives 
false negative results in patients with low parasite densi-
ties. Of the seven cases of asymptomatic parasitaemia, 
the RDT was positive in only one sample; on the other 
hand, the RDT detected all cases of symptomatic submi-
croscopic malaria except one. In P. falciparum malaria 
infection, HRP-2 is not secreted in the gametogony stage, 
so that the HRP-2 band may be absent in healthy carriers 
and may be overlooked.
C-PCR is easy to perform and it can be done fast at the 
same hospital. Also, it is standardized and has good diag-
nostic parameters (sensitivity 96%, specificity 97.38%, 
Kappa score 0.93), which were comparable with those 
of CNM-PCR. Among submicroscopic infections, eight 
discrepant results were found between the two PCR 
techniques: two in the symptomatic group and six in the 
asymptomatic group. The discrepancies in the asympto-
matic group could be due to low parasitaemia levels. The 
two discrepant results in the symptomatic group were 
detected only by RDT and C-PCR, whereas microscopy 
and CNM-PCR were negative. It is normal to find some 
variability in sensitivity scores between different PCR 
methods [20], attributable to the intrinsic variability of 
the technique, the specific target detected by the method, 
and differences in the extraction process (sample volume, 
elution volume). This is particularly important in mixed 
infections, since, although both molecular methods were 
able to detect at least one species, there were discrepan-
cies in eight cases. If only CNM-PCR or C-PCR had been 
performed, 5 and 2 of them, respectively, may have gone 
unnoticed.
After considering the results obtained at the study cen-
tre, the authors conclude that molecular methods show 
improved sensitivity over microscopy, mainly in asymp-
tomatic parasitaemias. The combination of microscopy 
and PCR upgraded the diagnosis of malaria, as the sen-
sitivity, specificity, VPP and VPN data demonstrate. Nev-
ertheless, PCR also has its disadvantages, since it detects 
non-viable parasites after malaria episodes that have 
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been correctly treated and this may lead to false positive 
results and unnecessary malaria treatments. In addition, 
it requires a sophisticated laboratory setting and trained 
technicians, requires a longer time to diagnosis and 
incurs higher costs [4]. For these reasons, probably none 
of these PCRs will be suitable enough to be included in 
the routine management at most malaria endemic set-
tings. Other nucleic acid amplification techniques are 
currently emerging, such as loop-mediated isothermal 
amplification (LAMP), which has comparable sensitiv-
ity to nested PCR and has also reduced assay times (to 
within 1 h) [21–23]. It is easy to use, since it needs only a 
compact incubator/reader that requires minimal training 
for laboratory technicians [21] and could be a potentially 
useful alternative mainly in endemic areas, to current 
molecular tools, which are more complex [24].
Plasmodium falciparum was the most prevalent spe-
cies diagnosed (96.6%). A low prevalence of malaria 
infections due to non-falciparum species was found, so 
that it was not possible to assess the diagnostic capac-
ity of the methods in these cases. Mixed infections were 
not very frequent. Co-infections were detected in only 
10 cases, all of them in the symptomatic group. Among 
co-infections, there were more discrepancies detected 
between the results obtained by CNM-PCR and C-PCR. 
Only two cases of mixed infections were detected by the 
two methods.
The prevalence of submicroscopic parasitaemia in the 
asymptomatic group (2.8%) was in line with data pub-
lished by Monge-Maillo et al. [25] and Matisz et al. [26], 
but was lower than that reported in others [17, 27]. Seven 
cases of asymptomatic parasitaemia were diagnosed only 
by molecular methods; all were due to P. falciparum. The 
two molecular methods were positive in only one case. 
It is important to bear in mind that some cases may go 
undetected due to variability between methods. Higher 
sensitivity would be desirable to ensure a proper diagno-
sis and prompt treatment of malaria infection.
The study has some underlying limitations. It was not 
possible to perform all the diagnostic tests on all sam-
ples for various reasons. First, factors associated with this 
group of immigrant patients (difficult social situation, 
legal problems, language/cultural barrier) made it diffi-
cult to include them in the study. Second, in most cases 
of malaria infection, the species responsible was P. falci-
parum, so that the usefulness of the methods for non-fal-
ciparum species was not possible to assess. Third, there 
were too few cases of mixed infections to evaluate the 
usefulness of these methods for diagnosis. In this type of 
infection, one of the species involved is usually present 
in a smaller proportion and cannot be detected. Further 
studies are required to assess this problem.
Conclusions
The FTD-Malaria and Malaria Differentiation PCRs 
showed good test values for the diagnostic test param-
eters (sensitivity, specificity, positive and negative pre-
dictive values and likelihood ratios), as well as good 
inter-procedure agreement for detecting malaria 
infections.
The population of immigrants originating from 
malaria-endemic areas can have low parasite blood den-
sities that non-molecular methods fail to detect. PCR is a 
useful tool for early detection of this type of infection. In 
this study, the combination of two molecular techniques 
enabled 14 cases (1.6%) of submicroscopic infection to be 
detected. Molecular techniques are also the most reliable 
tests to make a correct diagnosis of Plasmodium spe-
cies and mixed infections that, due to the subjectivity of 
microscopy, can be misdiagnosed.
The data obtained in this study are in agreement with 
other published reports and suggest that, while micros-
copy is very useful and faster, PCR is more sensitive and 
improves the diagnosis of malaria, above all in patients 
with undetectable parasitaemia. These data show that 
PCR is a diagnostic tool with efficiency, sensitivity and 
specificity greater than 96% for the diagnosis of malaria 
infections. Further research should be carried out to 
evaluate the usefulness of PCR and assess the real preva-
lence of submicroscopic infections.
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